FDA Clears First Blood-Based Biomarker Test for Alzheimer's: What It Means for Patients and Providers Diagnosing Alzheimer’s disease could be as simple as a routine blood draw thanks to the FDA’s recent clearance of the Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio test from Fujirebio. This innova... Alzheimer's biomarkers diagnostics FDA clearance Fujirebio neurodegenerative diseases plasma test
Faster, More Accurate Bacterial Identification: How Advanced Nucleic Acid Probes Are Transforming Diagnostics Speeding Up Life-Saving Diagnoses in Infectious Diseases Identifying dangerous bacteria quickly is essential for treating infections like sepsis, where every minute counts. Traditional diagnostic meth... diagnostics FISH infectious diseases microbiology molecular biology PNA probes sepsis
AI Revolutionizes How Scientists Map Protein Locations in Human Cells What if researchers could diagnose diseases or develop breakthrough drugs in a fraction of the time it takes today? Thanks to a cutting-edge artificial intelligence model from MIT, Harvard, and the Br... Alzheimer's artificial intelligence biomedical research cell biology diagnostics drug discovery machine learning protein localization